SCHEMBL7987310

SCHEMBL7987310

Oc1nc(-c2cccc(F)c2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GLA P06280 1/20 0.41
HTT P42858 1/20 0.41
UBE2N P61088 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GRIN2B Q13224 2/20 0.40
GRIN1 Q05586 1/20 0.40
ACP1 P24666 2/20 0.40
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
LMNA P02545 1/20 0.38
CNR2 P34972 1/20 0.38
HSD17B13 Q7Z5P4 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KDM4E B2RXH2 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
MAPK1 P28482 1/20 0.37
HTR6 P50406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985360 0.96 POLB (0.40) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7991669 0.92 HDAC1 (0.38) ACP1HSD17B13HDAC1HDAC6CDK9
SCHEMBL7973626 0.92 SMN1; SMN2 (0.45) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7987253 0.91 HPGDS (0.40) SMN1; SMN2ACP1HDAC1HDAC6MAPK1
SCHEMBL7988817 0.91 SMN1; SMN2 (0.43) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7988781 0.89 MET (0.43) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7991646 0.89 SMN1; SMN2 (0.43) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7988734 0.89 MET (0.44) ACP1LMNAHSD17B13HDAC1HDAC6
SCHEMBL7988668 0.89 SMN1; SMN2 (0.44) YTHDC1SMN1; SMN2GLAHTTUBE2N
SCHEMBL7991566 0.88 ACP1 (0.43) YTHDC1SMN1; SMN2GLAHTTUBE2N

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed